Fundraising Fox

Dance Biopharm Holdings

Brisbane, US · Founded 2013 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

Dance Biopharm Holdings was founded in 2013 by John S. Patton, Ph.D.

JS
John S. Patton, Ph.DFounder
TM
Tyler Martin, M.D.Executive
GZ
Greg ZanteExecutive
LE
Lisa E. Porter, M.D.Executive

Board

AS
Adam SternBoard director
AP
Augustine P.Y. Chow, M.D.Board director
DD
Donald D. HuffmanBoard director

Investors · 1

Hatteras Venture PartnersreportedResearch Triangle · $500K – $4Mvia Kenneth B. Lee, Jr. · board

Reported raises · per SEC filings

Form D private placements

$87.5M disclosed across 9 rounds · 2015–2023

▶$1MraisedNov 2023 · 30 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary C. BurgessExecutive Officer
  • Anne C. WhitakerExecutive Officer, Director
  • Adam K. SternDirector
  • John S. PattonDirector
  • Steven ThorntonDirector
  • William Patrick WelchDirector
  • Joshua ZielExecutive Officer
  • Darlene Deptula-HicksExecutive Officer, Director
Offering amount
$20M
Amount sold
$1M
Sales commissions
$94K
Placement agents
Aegis Capital Corp.
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedDec 2022 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JOHN S. PATTONDirector
  • ADAM K. STERNDirector
  • BILL WELCHDirector
  • STEVEN THORNTONExecutive Officer, Director
  • DARLENE DEPTULA-HICKSDirector
  • BARRY DEUTSCHExecutive Officer
  • LISA YANEZExecutive Officer
  • ANNE C. WHITAKERDirector
Offering amount
$20M
Amount sold
$5.4M
Sales commissions
$636.7K
Placement agents
AEGIS CAPITAL CORP.
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.3MraisedNov 2021 · 238 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • TIMM CROWDERExecutive Officer
  • ANNE C. WHITAKERDirector
  • JOHN S. PATTONDirector
  • BILL WELCHDirector
  • ADAM STERNDirector
  • K JEFFREY BELLExecutive Officer
  • STEVE THORNTONExecutive Officer, Director
  • DARLENE DEPTULA-HICKSDirector
Offering amount
$22.3M
Amount sold
$22.3M
Sales commissions
$2.2M
Placement agents
AEGIS CAPITAL CORP.
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.6MraisedJun 2020 · 61 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • KENNETH B. LEE, JR.Director
  • TIMM CROWDERExecutive Officer
  • ANNE C. WHITAKERExecutive Officer, Director
  • BILL WELCHDirector
  • BENJAMIN WOLINDirector
  • STEVE THORNTONDirector
  • MICHAEL J. KASETAExecutive Officer
  • JOHN S. PATTONDirector
  • ADAM STERNDirector
Offering amount
$15M
Amount sold
$4.6M
Sales commissions
$1.4M
Placement agents
AEGIS CAPITAL CORP.
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedJun 2019 · 283 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John S. Patton, Ph.DExecutive Officer, Director
  • Anne WhitakerExecutive Officer, Director
  • Ben WolinDirector
  • Matt JenningsDirector
  • Steven ThorntonDirector
  • Adam K. SternDirector
  • Mike KasetaExecutive Officer
  • Dr. Melissa RhodesExecutive Officer
Offering amount
$59.2M
Amount sold
$21M
Sales commissions
$825.3K
Placement agents
Aegis Capital Corp
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19MraisedJan 2018 · 135 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven ThorntonDirector
  • Donald D. HuffmanExecutive Officer, Director
  • Vivian YanDirector
  • Adam K. SternDirector
  • Lisa E. Porter, M.D.Executive Officer
  • John S. Patton, Ph.DExecutive Officer, Director
Offering amount
$36.7M
Amount sold
$19M
Sales commissions
$1.4M
Placement agents
Aegis Capital Corp
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.4MraisedJun 2017 · 49 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald D. HuffmanExecutive Officer, Director
  • Lisa E. Porter, M.D.Executive Officer
  • Adam K. SternDirector
  • John S. Patton, Ph.DExecutive Officer, Director
  • Steven ThorntonDirector
  • Vivian YanDirector
Offering amount
$5M
Amount sold
$3.4M
Minimum investment
$10K
Sales commissions
$500K
Placement agents
Aegis Capital Corp
First sale
Apr 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$625KraisedAug 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald D. HuffmanDirector
  • Greg ZanteExecutive Officer
  • Lisa E. Porter, M.D.Executive Officer
  • John S. Patton, Ph.DExecutive Officer, Director
  • Vivian YanDirector
  • Adam SternDirector
Offering amount
$23M
Amount sold
$625K
Sales commissions
$2.3M
Placement agents
Aegis Capital Corp
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Dance Biopharm Holdings?
Dance Biopharm Holdings was founded by John S. Patton, Ph.D in 2013.
Who are Dance Biopharm Holdings's investors?
Dance Biopharm Holdings's investors include Hatteras Venture Partners.
How much funding has Dance Biopharm Holdings raised?
Dance Biopharm Holdings has disclosed $87.5M raised across 9 rounds.
Where is Dance Biopharm Holdings headquartered?
Dance Biopharm Holdings is headquartered in Brisbane, US.